Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States
- PMID: 21255746
- PMCID: PMC3026476
- DOI: 10.1016/j.jalz.2010.11.002
Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States
Abstract
Declines in heart disease and stroke mortality rates are conventionally attributed to reductions in cigarette smoking, recognition and treatment of hypertension and diabetes, effective medications to improve serum lipid levels and to reduce clot formation, and general lifestyle improvements. Recent evidence implicates these and other cerebrovascular factors in the development of a substantial proportion of dementia cases. Analyses were undertaken to determine whether corresponding declines in age-specific prevalence and incidence rates for dementia and cognitive impairment have occurred in recent years. Data spanning 1 or 2 decades were examined from community-based epidemiological studies in Minnesota, Illinois, and Indiana, and from the Health and Retirement Study, which is a national survey. Although some decline was observed in the Minnesota cohort, no statistically significant trends were apparent in the community studies. A significant reduction in cognitive impairment measured by neuropsychological testing was identified in the national survey. Cautious optimism appears justified.
Copyright © 2011 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts to disclose. The sponsors had neither a role in the analysis or interpretation of these data, nor in the content of the paper. Appropriate approval procedures were used concerning human subjects.
Figures




References
-
- Kinsella K, Wan H U.S. Census Bureau: International Population Reports, P95/09-1, An Aging World: 2008. US Census Bureau. Washington, DC: U.S. Government Printing Office; 2009.
-
- Wimo A, Jonsson L, Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord. 2006;21:175–181. - PubMed
-
- Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3:186–191. - PubMed
-
- Rocca WA. Dementia, Parkinson's disease, and stroke in Europe: a commentary. Neurology. 2000;54:S38–S40. - PubMed
-
- Fratiglioni L, Rocca WA. Epidemiology of Dementia. In: Boller F, Cappa S, editors. Handbook of Neuropsychology. 2nd ed. Volume 6. Amsterdam: Elsevier; 2001. pp. 193–215.
Publication types
MeSH terms
Grants and funding
- R03 AG029652/AG/NIA NIH HHS/United States
- R01 AG019805/AG/NIA NIH HHS/United States
- K08 AG019180/AG/NIA NIH HHS/United States
- U01AG019349/AG/NIA NIH HHS/United States
- R03AG029652/AG/NIA NIH HHS/United States
- R01 AG015911/AG/NIA NIH HHS/United States
- U01 AG006781/AG/NIA NIH HHS/United States
- U01AG009740/AG/NIA NIH HHS/United States
- U01 AG017155/AG/NIA NIH HHS/United States
- R01AG019805/AG/NIA NIH HHS/United States
- R01 AG017155/AG/NIA NIH HHS/United States
- R01AG011101/AG/NIA NIH HHS/United States
- U01 AG006786/AG/NIA NIH HHS/United States
- R01 AG034676/AG/NIA NIH HHS/United States
- U01 AG009740/AG/NIA NIH HHS/United States
- R01 AG009956/AG/NIA NIH HHS/United States
- K08AG019180/AG/NIA NIH HHS/United States
- R01AG015911/AG/NIA NIH HHS/United States
- R01AG027010/AG/NIA NIH HHS/United States
- R01AG009956/AG/NIA NIH HHS/United States
- U01AG06786/AG/NIA NIH HHS/United States
- U01 AG019349/AG/NIA NIH HHS/United States
- U01AG006781/AG/NIA NIH HHS/United States
- U01AG017155/AG/NIA NIH HHS/United States
- R01 AG027010/AG/NIA NIH HHS/United States
- R01 AG011101/AG/NIA NIH HHS/United States
- R01AG034676/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases